418 related articles for article (PubMed ID: 24836125)
1. Simvastatin for the prevention of exacerbations in moderate-to-severe COPD.
Criner GJ; Connett JE; Aaron SD; Albert RK; Bailey WC; Casaburi R; Cooper JA; Curtis JL; Dransfield MT; Han MK; Make B; Marchetti N; Martinez FJ; Niewoehner DE; Scanlon PD; Sciurba FC; Scharf SM; Sin DD; Voelker H; Washko GR; Woodruff PG; Lazarus SC; ;
N Engl J Med; 2014 Jun; 370(23):2201-10. PubMed ID: 24836125
[TBL] [Abstract][Full Text] [Related]
2. Low-dose oral theophylline combined with inhaled corticosteroids for people with chronic obstructive pulmonary disease and high risk of exacerbations: a RCT.
Devereux G; Cotton S; Fielding S; McMeekin N; Barnes PJ; Briggs A; Burns G; Chaudhuri R; Chrystyn H; Davies L; Soyza A; Gompertz S; Haughney J; Innes K; Kaniewska J; Lee A; Morice A; Norrie J; Sullivan A; Wilson A; Price D
Health Technol Assess; 2019 Jul; 23(37):1-146. PubMed ID: 31343402
[TBL] [Abstract][Full Text] [Related]
3. Combined aclidinium bromide and long-acting beta2-agonist for chronic obstructive pulmonary disease (COPD).
Ni H; Moe S; Soe Z; Myint KT; Viswanathan KN
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD011594. PubMed ID: 30536566
[TBL] [Abstract][Full Text] [Related]
4. Metoprolol for the Prevention of Acute Exacerbations of COPD.
Dransfield MT; Voelker H; Bhatt SP; Brenner K; Casaburi R; Come CE; Cooper JAD; Criner GJ; Curtis JL; Han MK; Hatipoğlu U; Helgeson ES; Jain VV; Kalhan R; Kaminsky D; Kaner R; Kunisaki KM; Lambert AA; Lammi MR; Lindberg S; Make BJ; Martinez FJ; McEvoy C; Panos RJ; Reed RM; Scanlon PD; Sciurba FC; Smith A; Sriram PS; Stringer WW; Weingarten JA; Wells JM; Westfall E; Lazarus SC; Connett JE;
N Engl J Med; 2019 Dec; 381(24):2304-2314. PubMed ID: 31633896
[TBL] [Abstract][Full Text] [Related]
5. Umeclidinium bromide versus placebo for people with chronic obstructive pulmonary disease (COPD).
Ni H; Htet A; Moe S
Cochrane Database Syst Rev; 2017 Jun; 6(6):CD011897. PubMed ID: 28631387
[TBL] [Abstract][Full Text] [Related]
6. Effect of Theophylline as Adjunct to Inhaled Corticosteroids on Exacerbations in Patients With COPD: A Randomized Clinical Trial.
Devereux G; Cotton S; Fielding S; McMeekin N; Barnes PJ; Briggs A; Burns G; Chaudhuri R; Chrystyn H; Davies L; De Soyza A; Gompertz S; Haughney J; Innes K; Kaniewska J; Lee A; Morice A; Norrie J; Sullivan A; Wilson A; Price D
JAMA; 2018 Oct; 320(15):1548-1559. PubMed ID: 30326124
[TBL] [Abstract][Full Text] [Related]
7. Twice daily N-acetylcysteine 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON): a randomised, double-blind placebo-controlled trial.
Zheng JP; Wen FQ; Bai CX; Wan HY; Kang J; Chen P; Yao WZ; Ma LJ; Li X; Raiteri L; Sardina M; Gao Y; Wang BS; Zhong NS;
Lancet Respir Med; 2014 Mar; 2(3):187-94. PubMed ID: 24621680
[TBL] [Abstract][Full Text] [Related]
8. Prophylactic antibiotics for adults with chronic obstructive pulmonary disease: a network meta-analysis.
Janjua S; Mathioudakis AG; Fortescue R; Walker RA; Sharif S; Threapleton CJ; Dias S
Cochrane Database Syst Rev; 2021 Jan; 1(1):CD013198. PubMed ID: 33448349
[TBL] [Abstract][Full Text] [Related]
9. Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD).
Herath SC; Normansell R; Maisey S; Poole P
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD009764. PubMed ID: 30376188
[TBL] [Abstract][Full Text] [Related]
10. Effect of Erdosteine on COPD Exacerbations in COPD Patients with Moderate Airflow Limitation.
Calverley PM; Page C; Dal Negro RW; Fontana G; Cazzola M; Cicero AF; Pozzi E; Wedzicha JA
Int J Chron Obstruct Pulmon Dis; 2019; 14():2733-2744. PubMed ID: 31819405
[TBL] [Abstract][Full Text] [Related]
11. Can simvastatin reduce COPD exacerbations? A randomised double-blind controlled study.
Schenk P; Spiel AO; Hüttinger F; Gmeiner M; Fugger J; Pichler M; Pichler G; Schmeikal S; Janistyn W; Schügerl S; Sajdik C; Herkner H
Eur Respir J; 2021 Jul; 58(1):. PubMed ID: 33574076
[TBL] [Abstract][Full Text] [Related]
12. Statins versus placebo for people with chronic obstructive pulmonary disease.
Walsh A; Perrem L; Khashan AS; Henry MT; Ni Chroinin M
Cochrane Database Syst Rev; 2019 Jul; 7(7):CD011959. PubMed ID: 31425628
[TBL] [Abstract][Full Text] [Related]
13. Long-acting beta2-agonists for chronic obstructive pulmonary disease.
Kew KM; Mavergames C; Walters JA
Cochrane Database Syst Rev; 2013 Oct; (10):CD010177. PubMed ID: 24127118
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular and inflammatory effects of simvastatin therapy in patients with COPD: a randomized controlled trial.
John ME; Cockcroft JR; McKeever TM; Coward WR; Shale DJ; Johnson SR; Thornton JG; Harrison TW; Knox AJ; Bolton CE
Int J Chron Obstruct Pulmon Dis; 2015; 10():211-21. PubMed ID: 25673981
[TBL] [Abstract][Full Text] [Related]
15. Benralizumab for chronic obstructive pulmonary disease and sputum eosinophilia: a randomised, double-blind, placebo-controlled, phase 2a study.
Brightling CE; Bleecker ER; Panettieri RA; Bafadhel M; She D; Ward CK; Xu X; Birrell C; van der Merwe R
Lancet Respir Med; 2014 Nov; 2(11):891-901. PubMed ID: 25208464
[TBL] [Abstract][Full Text] [Related]
16. Phosphodiesterase-4 inhibitors for chronic obstructive pulmonary disease.
Janjua S; Fortescue R; Poole P
Cochrane Database Syst Rev; 2020 May; 5(5):CD002309. PubMed ID: 32356609
[TBL] [Abstract][Full Text] [Related]
17. Aclidinium bromide for stable chronic obstructive pulmonary disease.
Ni H; Soe Z; Moe S
Cochrane Database Syst Rev; 2014 Sep; 2014(9):CD010509. PubMed ID: 25234126
[TBL] [Abstract][Full Text] [Related]
18. Benefits of glycopyrrolate/formoterol fumarate metered dose inhaler (GFF MDI) in improving lung function and reducing exacerbations in patients with moderate-to-very severe COPD: a pooled analysis of the PINNACLE studies.
Martinez FJ; Lipworth BJ; Rabe KF; Collier DJ; Ferguson GT; Sethi S; Feldman GJ; O'Brien G; Jenkins M; Reisner C
Respir Res; 2020 May; 21(1):128. PubMed ID: 32450869
[TBL] [Abstract][Full Text] [Related]
19. Blood eosinophil-guided oral prednisolone for COPD exacerbations in primary care in the UK (STARR2): a non-inferiority, multicentre, double-blind, placebo-controlled, randomised controlled trial.
Ramakrishnan S; Jeffers H; Langford-Wiley B; Davies J; Thulborn SJ; Mahdi M; A'Court C; Binnian I; Bright S; Cartwright S; Glover V; Law A; Fox R; Jones A; Davies C; Copping D; Russell RE; Bafadhel M
Lancet Respir Med; 2024 Jan; 12(1):67-77. PubMed ID: 37924830
[TBL] [Abstract][Full Text] [Related]
20. Fluticasone furoate and vilanterol and survival in chronic obstructive pulmonary disease with heightened cardiovascular risk (SUMMIT): a double-blind randomised controlled trial.
Vestbo J; Anderson JA; Brook RD; Calverley PM; Celli BR; Crim C; Martinez F; Yates J; Newby DE;
Lancet; 2016 Apr; 387(10030):1817-26. PubMed ID: 27203508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
